Posted By:
NatureMed Oncology
Category:
Integrative Cancer Support
NatureMed Clinic's Dr. Kirsten West contributed a study regarding topical milk thistle for Capecitabine-Induced Hand-Foot Syndrome to the Natural Medicine Journal. Forty patients diagnosed with gastrointestinal malignancy, including colorectal and esophageal cancers, who had no previous exposure to capecitabine but were scheduled to receive this medication; average age was 60 years and 60% were male. Gastric cancer was the most common malignancy in both the treatment and placebo groups (75% and 60%, respectively). Topical Milk Thistle for Capecitabine-Induced Hand-Foot Syndrome Reference Elyasi S, Shojaee FSR, Allahyari A, Karimi G. Topical silymarin administration for prevention of capecitabine-induced hand-foot syndrome: a randomized, double-blinded, placebo-controlled clinical trial. Phytother Res. 2017;31(9):1323-1329. Objective To assess if topical silymarin is active in the prevention of capecitabine-induced hand-foot syndrome (HFS) Design Pilot, randomized, double-blinded, placebo-controlled clinical trial Participants Forty patients diagnosed with gastrointestinal malignancy, including colorectal and esophageal cancers, who had no previous exposure to capecitabine but were scheduled to receive this medication; average age was 60 years and 60% were male. Gastric cancer was the most common malignancy in both the treatment and placebo groups (75% and 60%, respectively). Study Medication and Dosage Patients were randomly allocated to either the topical silymarin (treatment) or placebo group. Those...